As of 2024-12-15, the Relative Valuation of Editas Medicine Inc (EDIT) is (51.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.44 USD, the upside of Editas Medicine Inc based on Relative Valuation is -3700.4%.
The range of the Relative Valuation is (49.03) - (58.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 24.0x | 19.8x |
| Forward P/E multiples | 19.2x - 22.8x | 20.8x |
| Fair Price | (49.03) - (58.16) | (51.85) |
| Upside | -3504.7% - -4138.8% | -3700.4% |
| Date | P/E |
| 2024-12-13 | -0.56 |
| 2024-12-12 | -0.74 |
| 2024-12-11 | -0.78 |
| 2024-12-10 | -0.82 |
| 2024-12-09 | -0.87 |
| 2024-12-06 | -0.84 |
| 2024-12-05 | -0.75 |
| 2024-12-04 | -0.78 |
| 2024-12-03 | -0.78 |
| 2024-12-02 | -0.86 |
| 2024-11-29 | -0.88 |
| 2024-11-27 | -0.86 |
| 2024-11-26 | -0.87 |
| 2024-11-25 | -0.93 |
| 2024-11-22 | -0.96 |
| 2024-11-21 | -0.93 |
| 2024-11-20 | -0.94 |
| 2024-11-19 | -0.97 |
| 2024-11-18 | -0.99 |
| 2024-11-15 | -1.04 |
| 2024-11-14 | -1.09 |
| 2024-11-13 | -1.16 |
| 2024-11-12 | -1.20 |
| 2024-11-11 | -1.29 |
| 2024-11-08 | -1.22 |
| 2024-11-07 | -1.24 |
| 2024-11-06 | -1.29 |
| 2024-11-05 | -1.22 |
| 2024-11-04 | -1.13 |
| 2024-11-01 | -1.14 |
| 2024-10-31 | -1.14 |
| 2024-10-30 | -1.18 |
| 2024-10-29 | -1.22 |
| 2024-10-28 | -1.28 |
| 2024-10-25 | -1.25 |
| 2024-10-24 | -1.25 |
| 2024-10-23 | -1.26 |
| 2024-10-22 | -1.29 |
| 2024-10-21 | -1.47 |
| 2024-10-18 | -1.32 |
| 2024-10-17 | -1.30 |
| 2024-10-16 | -1.35 |
| 2024-10-15 | -1.32 |
| 2024-10-14 | -1.27 |
| 2024-10-11 | -1.25 |
| 2024-10-10 | -1.16 |
| 2024-10-09 | -1.22 |
| 2024-10-08 | -1.24 |
| 2024-10-07 | -1.26 |
| 2024-10-04 | -1.33 |